Conditions such as advanced chronic kidney disease or HIV now carry greater weight in determining statin candidacy.
>>> Sophie, Duchess of Edinburgh, Debuts Distinctive Summer Outfits with Unexpected Choices
Personalized Decisions and Lifestyle Remain Key
“Eligibility means that statin therapy should be considered,” said Dr. Leana Wen, emergency physician and clinical associate professor at George Washington University.
She emphasized that qualifying for statins does not imply an automatic prescription, but rather prompts personalized discussions between patients and clinicians.
To evaluate candidacy, clinicians use a full lipid panel, medical history, and the PREVENT calculator.
Additional tools like coronary artery calcium CT scans help clarify risk for borderline or intermediate patients.
“The goal is to identify people who may benefit from reducing cholesterol earlier rather than waiting until their 10-year risk becomes high,” Dr. Wen added.
A third study in JAMA noted that 82.7% of high-risk primary prevention patients remain above recommended LDL target levels, highlighting persistent gaps in cholesterol management.
In an accompanying editorial, JAMA editors Philip Greenland and Karen Lasser urged healthcare systems to improve patient education, multidisciplinary care, and coverage access.
Lifestyle modifications including a healthy diet, regular exercise, weight management, and smoking cessation remain foundational for cardiovascular risk reduction.
“Lifestyle measures remain essential for everyone,” Dr. Wen said.
Although statins are the primary therapy, alternative non-statin treatments are emerging, including the recently FDA-approved oral PCSK9 inhibitor enlicitide.
>>> Leeds United Unveils 2026-27 Home Kit Honoring City's 400-Year Legacy
“The first step is to know your numbers,” Dr. Wen concluded.
